Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 17, 1997

View Archived Issues

AIDS rate increases among women

Initial phase III results reported for KeraVision Ring

Highlights from the Japanese Society of Bone Metabolism Research

Dopamine D3 receptor-selective CNS agents disclosed by BASF

Takeda claims new carbapenems

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

Pharmacia & Upjohn discovers potent camptothecin analogues

Antiviral benzimidazole compounds prepared at Glaxo Wellcome

Genentech discovers new cytokine inducing apoptosis

Meiji Milk introduces new hepatitis B vaccine

Bisulfated peptide may be clinically useful in venous thrombotic disorders

Thailand grants first approval for WF-10

First U.S. clinical trial of pranlukast

Major clinical trial results on ziprasidone presented at neuropsychopharmacology congress

Role of IL-1 receptors in osteoporosis elucidated

Searle evaluates novel target for antifungal agents

Generic version of pediatric ibuprofen receives tentative approval from FDA

A-127722.5, a selective, orally active ETA antagonist for restenosis

PDL grants antibody humanization patent license to NeoRx

Duke University granted orphan drug status for Pompe's disease therapy

Further demonstrations of Zomig efficacy in migraine

ArnaX receives SBIR grant for AD research

Cambridge NeuroScience discontinues Cerestat trial for TBI

Novopharm Biotech seeks approval for melanoma vaccine trial

Biovail licenses diltiazem for Scandinavian market

CD45RB antibody available for licensing from RCT

Transdermal lidocaine patch enters phase II/III for allergic rhinitis